Celularity Inc (CELU) Insider Ownership

Historic Insider Ownership Trends

According to recent filings covering the 90 days ending February 19, 2026, the three most significant insider holders at Celularity are Director Kok Thay Lim (6.36Mn shares), Chief Executive Officer Robert J Hariri (2.85Mn shares), TenPercentOwner International Co Inc Starr (1.53Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
International Co Inc Starr 1,528,139 15 Mar, 2022
Kok Thay Lim 6,358,152 30 Jun, 2023
Therapeutics, Inc. Sorrento 505,043 05 Oct, 2023
Robert J Hariri Chief Executive Officer 2,851,454 04 Jun, 2025
Adrian Kilcoyne Chief Medical Officer 112,224 21 Feb, 2024
John Sculley 100,466 16 Jun, 2023
Diane L. Parks 520,021 15 Jan, 2026
Dean C Kehler 313,482 06 Jan, 2025
Peter Diamandis 394,150 15 Jan, 2026
Bradley Glover Nan 35,119 17 Apr, 2023
Eschenbach Andrew C. Von 33,607 16 Jun, 2023
Geoffrey M.D. Ling 256,026 15 Jan, 2026
Robin L Smith 23,607 16 Jun, 2023
Marc Mazur 23,607 16 Jun, 2023
Vincent Levien 153,847 15 Jan, 2026
Jay R Bloom 10,000 20 Jul, 2021
Sponsor Llc Gx 10,000 20 Jul, 2021
Richard J Berman 67,416 06 Jan, 2025
John R Haines Senior Exec Vice President 29,121 15 Apr, 2025
Anne Jones Chief Business Officer 2,789 15 Jul, 2022
Kyle Fletcher Nan 21,085 16 Apr, 2024
David C Beers Chief Financial Officer 18,201 15 Apr, 2025
Keary Dunn Nan 1,641 28 Apr, 2022
Stephen Brigido Pres. And Functional Regeneration 8,921 15 Apr, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
12 Jan, 2026 Peter Diamandis Class A Common Stock A 20,385 $0.00 394,150 D A
12 Jan, 2026 Peter Diamandis Class A Common Stock A 20,385 $0.00 394,150 D A
12 Jan, 2026 Diane L. Parks Class A Common Stock A 30,000 $0.00 520,021 D A
12 Jan, 2026 Diane L. Parks Class A Common Stock A 30,000 $0.00 520,021 D A
12 Jan, 2026 Geoffrey M.D. Ling Class A Common Stock A 19,231 $0.00 256,026 D A
12 Jan, 2026 Geoffrey M.D. Ling Class A Common Stock A 19,231 $0.00 256,026 D A
12 Jan, 2026 Vincent Levien Class A Common Stock A 28,847 $0.00 153,847 D A
12 Jan, 2026 Vincent Levien Class A Common Stock A 28,847 $0.00 153,847 D A
29 Dec, 2025 Peter Diamandis Class A Common Stock A 125,000 $0.00 373,765 D A
29 Dec, 2025 Diane L. Parks Class A Common Stock A 125,000 $0.00 490,021 D A
29 Dec, 2025 Geoffrey M.D. Ling Class A Common Stock A 125,000 $0.00 236,795 D A
29 Dec, 2025 Vincent Levien Class A Common Stock A 125,000 $0.00 125,000 D A
19 Dec, 2025 Peter Diamandis Class A Common Stock A 67,416 $0.00 248,765 D A
19 Dec, 2025 Diane L. Parks Class A Common Stock A 67,416 $0.00 365,021 D A
19 Dec, 2025 Geoffrey M.D. Ling Class A Common Stock A 67,416 $0.00 111,795 D A
19 Nov, 2025 Peter Diamandis Class A Common Stock A 47,042 $0.00 248,765 D A
19 Nov, 2025 Diane L. Parks Class A Common Stock A 61,539 $0.00 365,021 D A
19 Nov, 2025 Geoffrey M.D. Ling Class A Common Stock A 44,379 $0.00 111,795 D A
19 Nov, 2025 Vincent Levien Class A Common Stock A 3,699 $0.00 3,699 D A
13 Apr, 2025 Robert J Hariri Class A Common Stock A 3,281 $0.00 2,852,608 D M